DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ilaris (Canakinumab) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (22)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ilaris (Canakinumab) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ilaris side effects in female

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-08-23

Patient: female

Reactions: Parvovirus Infection, Histiocytosis Haematophagic, General Physical Health Deterioration, Pyrexia, Rash, Serum Ferritin Increased, Bone Marrow Disorder, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Methotrexate; Prednisolone; Calcigran; Omeprazole (Prisolec); Folic Acid



Possible Ilaris side effects in female

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-08-13

Patient: female

Reactions: Parvovirus Infection, Histiocytosis Haematophagic, General Physical Health Deterioration, Rash, Pyrexia, Serum Ferritin Increased, Bone Marrow Disorder, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: 150 mg (dose was reduced to half)

Ilaris
    Dosage: 300 mg every 4th week
    Indication: Juvenile Arthritis
    Start date: 2011-05-01

Other drugs received by patient: Calcigran; Folic Acid; Omeprazole (Prisolec); Prednisolone; Methotrexate



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-07-23

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Respiratory Failure, Interstitial Lung Disease, Anaemia, Coagulopathy, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amiodarone HCL
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-01-20
    End date: 2012-06-07

Xarelto
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2011-12-30
    End date: 2012-06-07

Ilaris
    Dosage: unk
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-07-08
    End date: 2012-04-23

Other drugs received by patient: Aspirin; Lisinopril; Carvedilol; Potassium Chloride; Lipitor; Lasix



Possible Ilaris side effects in female

Reported by a physician from Israel on 2012-07-23

Patient: female, weighing 17.0 kg (37.4 pounds)

Reactions: Device Related Sepsis, Histiocytosis Haematophagic, Pneumonia, Gastroenteritis, Septic Shock, Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Amoxicillin; Iron; Methylprednisolone; Methotrexate; Vitamin D



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-07-10

Patient: male, weighing 104.3 kg (229.5 pounds)

Reactions: Bladder Cancer

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ilaris
    Dosage: double blinded
    Start date: 2011-09-09

Placebo
    Dosage: double blinded
    Indication: Gouty Arthritis
    Start date: 2011-09-09

Triamcinolone Acetonide
    Dosage: double blinded
    Indication: Gouty Arthritis
    Start date: 2011-09-09

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Gouty Arthritis
    Start date: 2011-09-09

Ilaris
    Dosage: double blinded
    Indication: Gouty Arthritis
    Start date: 2011-09-09

Other drugs received by patient: Remeron; Depakote; Allopurinol; Colchicine; Losartan Potassium; Risperdal



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-06-21

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Interstitial Lung Disease, Respiratory Failure, Anaemia, Coagulopathy, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amiodarone HCL
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-01-20
    End date: 2012-06-07

Ilaris
    Dosage: unk
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-07-08
    End date: 2012-04-23

Other drugs received by patient: Lisinopril; Potassium Chloride; Carvedilol; Aspirin; Lipitor; Xarelto; Lasix



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-06-20

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Interstitial Lung Disease, Respiratory Failure, Coagulopathy, Anaemia, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: unk
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-07-08
    End date: 2012-04-23

Amiodarone HCL
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-01-20
    End date: 2012-06-07

Other drugs received by patient: Lisinopril; Aspirin; Carvedilol; Xarelto; Lasix; Potassium Chloride; Lipitor



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-06-15

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: International Normalised Ratio Increased, Coagulopathy, Anaemia, Atrial Fibrillation, Disease Progression, Hypokalaemia, Respiratory Failure, Interstitial Lung Disease, Blood Glucose Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amiodarone HCL
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-01-20
    End date: 2012-06-07

Ilaris
    Dosage: unk
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-07-08
    End date: 2012-04-23

Other drugs received by patient: Carvedilol; Xarelto; Aspirin; Potassium Chloride; Lasix; Lisinopril; Lipitor



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-06-15

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Respiratory Failure, Interstitial Lung Disease, Coagulopathy, Anaemia, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: unk
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-07-08
    End date: 2012-04-23

Amiodarone HCL
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-01-20
    End date: 2012-06-07

Other drugs received by patient: Lisinopril; Lipitor; Potassium Chloride; Xarelto; Carvedilol; Aspirin; Lasix



Possible Ilaris side effects in female

Reported by a physician from Israel on 2012-06-04

Patient: female, weighing 17.0 kg (37.4 pounds)

Reactions: Gastroenteritis, Septic Shock, Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Vitamin D; Amoxicillin; Iron; Methylprednisolone; Methotrexate



Possible Ilaris side effects in female

Reported by a physician from Israel on 2012-05-24

Patient: female, weighing 17.0 kg (37.4 pounds)

Reactions: Gastroenteritis, Septic Shock, Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Methylprednisolone; Vitamin D; Amoxicillin; Iron; Methotrexate



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-05-15

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Palpitations, Angina Unstable, Suicide Attempt, Concomitant Disease Progression, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Metoprolol Succinate Extended Release
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2012-05-01

Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Metoprolol Succinate Extended Release
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2011-06-17
    End date: 2012-04-30

Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Other drugs received by patient: Trazodone HCL; Buspar; Aspirin; Trazodone HCL; Effexor; Effexor; Effexor; Effexor; Buspar



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-05-11

Patient: male, weighing 115.3 kg (253.7 pounds)

Reactions: Cellulitis, Beta Haemolytic Streptococcal Infection, Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Simvastatin; Effient; Lisinopril; Bystolic; Niaspan; Zocor; Aspirin



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-05-08

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Palpitations, Angina Unstable, Suicide Attempt, Concomitant Disease Progression, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Metoprolol Succinate Extended Release
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2011-06-17
    End date: 2012-04-30

Metoprolol Succinate Extended Release
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2012-05-01

Other drugs received by patient: Buspar; Buspar; Effexor; Effexor; Trazodone HCL; Aspirin; Effexor



Possible Ilaris side effects in male

Reported by a physician from Turkey on 2012-03-12

Patient: male, weighing 32.0 kg (70.4 pounds)

Reactions: Histiocytosis Haematophagic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: 0.80 ml, unk
    Indication: Juvenile Arthritis
    Start date: 2011-11-30

Ilaris
    Dosage: 0.86 ml, unk
    Start date: 2011-12-26

Ilaris
    Dosage: 0.88 ml, unk
    Start date: 2012-02-22

Ilaris
    Dosage: 0.85 ml, unk
    Start date: 2012-01-23



Possible Ilaris side effects in male

Reported by a physician from Turkey on 2012-03-09

Patient: male, weighing 32.0 kg (70.4 pounds)

Reactions: Histiocytosis Haematophagic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: 0.80 ml, unk
    Indication: Juvenile Arthritis
    Start date: 2011-11-30

Ilaris
    Dosage: 0.85 ml, unk
    Start date: 2012-01-23

Ilaris
    Dosage: 0.88 ml, unk
    Start date: 2012-02-22

Ilaris
    Dosage: 0.86 ml, unk
    Start date: 2011-12-26



Possible Ilaris side effects in male

Reported by a physician from Turkey on 2012-03-05

Patient: male, weighing 32.0 kg (70.4 pounds)

Reactions: Viral Infection, Histiocytosis Haematophagic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: 0.86 ml, unk
    Start date: 2011-12-26

Ilaris
    Dosage: 0.85 ml, unk
    Start date: 2012-01-23

Ilaris
    Dosage: 0.80 ml, unk
    Indication: Juvenile Arthritis
    Start date: 2011-11-30

Ilaris
    Dosage: 0.88 ml, unk
    Start date: 2012-02-22



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-03-02

Patient: male, weighing 115.3 kg (253.7 pounds)

Reactions: Cellulitis, Beta Haemolytic Streptococcal Infection, Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Zocor; Lisinopril; Bystolic; Aspirin; Simvastatin; Effient; Niaspan



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-01-20

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Suicide Attempt, Concomitant Disease Progression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Metoprolol Succinate Extended Release

Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Other drugs received by patient: Effexor; Effexor; Effexor



Possible Ilaris side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Suicide Attempt, Concomitant Disease Progression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Metoprolol Succinate Extended Release

Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Other drugs received by patient: Effexor; Effexor



Possible Ilaris side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-21

Patient: male, weighing 115.3 kg (253.7 pounds)

Reactions: Cellulitis, Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Zocor; Effient; Lisinopril; Simvastatin; Niaspan; Aspirin; Bystolic



Possible Ilaris side effects in male

Reported by a physician from United States on 2011-10-13

Patient: male, weighing 70.7 kg (155.5 pounds)

Reactions: Productive Cough, Pneumonia, Wheezing, Disease Progression, Fatigue, Dyspnoea Exertional, Respiratory Failure, Pulmonary Congestion, Sputum Discoloured, Lung Infiltration, Asthenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Stool Softener; Flomax; Prednisone; Lasix; Vitamin D; Fish OIL; Theophylline; Spiriva; Advair Diskus 100 / 50

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017